Welcome
ATOPIC ECZEMA RESEARCH
New Research Study is enrolling patients ages 18 to 70 years old. See if you qualify!
Learn More about a new Research Study for affected patients.
PURPOSE OF THE STUDY
The purpose of this study is to evaluate the efficacy and safety of the investigational study medication in adults with moderate to severe Atopic Dermatitis, also known as Eczema. The study medication is an injection under the skin.
Who may participate in this study?
You may qualify for this research study, if the following applies to you:
You are between 18-70 years old.
Your Atopic Dermatitis is Moderate to Severe.
Minimum of 10% eczema affected body surface area to be determined by study doctor at screening visit.
QUALIFY
There are other eligibility requirements. A final decision on whether this research study might be suitable for you will be made after you speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in this research study.
REIMBURSEMENT
You may receive reimbursement for your time and travel expenses related to study participation.
Learn More About Our Team
